Diagnostic imaging of hepatocellular carcinoma: Recent progress

Oncology

Volumn 81, Issue SUPPL. 1, 2011, Pages 73-85

  Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced ultrasound; Defect reperfusion imaging; Double contrast ultrasound; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging; Hepatocellular carcinoma; Sonazoid; Sonazoid contrast enhanced ultrasound

Indexed keywords

GADOXETIC ACID; PERFLUBUTANE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; B SCAN; CANCER DIAGNOSIS; CANCER STAGING; CELL FUNCTION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; KUPFFER CELL; LIVER ARTERIOGRAPHY; LIVER CELL; LIVER CELL CARCINOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE; VASCULARIZATION;

ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FERRIC COMPOUNDS; GADOLINIUM DTPA; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; OXIDES; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 84855317655     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000333265     Document Type: Article

References (67)

1. Kudo M: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Tokyo, Springer, 2003, pp 1-253.
2. Kudo M, Hatanaka K, Maekawa K: Defect reperfusion imaging, a newly developed novel technology using Sonazoid in the treatment of hepatocellular carcinoma. J Med Ultrasound 2008; 16: 169-175.
3. Kudo M, Hatanaka K, Maekawa K: Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology 2010; 78(suppl 1):40-45.
4. Makuuchi M, Kokudo N, Arii S, Igaki H, Ikai I, Kaneko S, et al: Surveillance algorithm and diagnostic algorithm for hepatocellular carcinoma. Hepatol Res 2010; 40(suppl 1):1-144.
5. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al: Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guideline Proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
6. Bruix J, Sherman M: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430. (Pubitemid 32844200)
8. Hatanaka K, Chung H, Kudo M, Haji S, Minami Y, Maekawa K, et al: Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Oncology 2010; 78(suppl 1):53-59.
9. Hatanaka K, Kudo M, Minami Y, Maekawa K: Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75(suppl 1):42-47.
10. Kudo M, Hatanaka K, Kumada T, Toyoda H, Tada T: Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma. Am J Gastroenterol 2011; 106: 368-370.
11. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, et al: Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51:S61-69.
12. Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, et al: Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004; 182: 1019-1026. (Pubitemid 38391667)
13. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K: Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220: 349-356. (Pubitemid 32667169)
14. Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y, et al: Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2005; 40: 1139-1147. (Pubitemid 43124841)
15. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2001; 176: 661-666. (Pubitemid 32181962)
16. Minami Y, Kudo M, Kawasaki T, Kitano M, Chung H, Maekawa K, et al: Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 180: 703-708. (Pubitemid 36237212)
17. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Chung H, et al: Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221: 721-730. (Pubitemid 33101764)
18. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H: Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004; 183: 153-156. (Pubitemid 38789029)
19. Minami Y, Kudo M, Chung H, Kawasaki T, Yagyu Y, Shimono T, et al: Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007; 188: 489-494. (Pubitemid 46167751)
20. Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, et al: Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 181: 57-63. (Pubitemid 36741461)
21. Minami Y, Kudo M, Hatanaka K, Kitai S, Inoue T, Hagiwara S, et al: Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010; 30: 759-764.
22. Minami Y, Kudo M: Hepatic malignancies: correlation between sonographic findings and pathological features. World J Radiol 2010; 2: 249-256.
23. Kudo M: Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78(suppl 1):113-124.
24. Inoue T, Minami Y, Chung H, Hayaishi S, Ueda T, Tatsumi C, et al: Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases. Oncology 2010; 78(suppl 1):94-101.
25. Minami Y, Kudo M: Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocelular carcinomaprimary hepatocelular carcinoma. World J Radiol 2009; 31: 86-91.
26. Kudo M: Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 2004; 39: 205-214.
27. Zhou P, Kudo M, Minami Y, Chung H, Inoue T, Fukunaga T, et al: What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology 2007; 72(suppl 1):92-97. (Pubitemid 350256671)
28. Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, et al: Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008; 190:W335-341. (Pubitemid 351798535)
29. Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, et al: Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007; 72(suppl 1):111-116. (Pubitemid 350256674)
30. Minami Y, Kudo M: Radiofrequency ablation of hepatocellular carcinoma: current status. World J Radiol 2010; 2: 417-424.
31. Kawata S, Murakami T, Kim T, Hori M, Federle MP, Kumano S, et al: Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 2002; 179: 61-66. (Pubitemid 34694812)
32. Haider MA, Amitai MM, Rappaport DC, O'Malley ME, Hanbidge AE, Redston M, et al: Multi-detector row helical CT in preoperative assessment of small (< or =1.5 cm) liver metastases: is thinner collimation better? Radiology 2002; 225: 137-142.
33. Kim T, Murakami T, Hori M, Takamura M, Takahashi S, Okada A, et al: Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol 2002; 178: 899-904. (Pubitemid 34250226)
34. Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, et al: Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001; 218: 763-767. (Pubitemid 32172560)
35. Ichikawa T, Kitamura T, Nakajima H, Sou H, Tsukamoto T, Ikenaga S, et al: Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol 2002; 179: 751-758. (Pubitemid 34919593)
36. Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, et al: Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 2003; 226: 543-549. (Pubitemid 36313447)
37. Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, et al: Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 2003; 180: 1217-1224. (Pubitemid 36504605)
38. Lee KH, O'Malley ME, Haider MA, Hanbidge A: Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 2004; 182: 643-649. (Pubitemid 38269524)
39. Tanikake M, Shimizu T, Narabayashi I, Matsuki M, Masuda K, Yamamoto K, et al: Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent. Radiology 2003; 227: 883-889. (Pubitemid 36583052)
40. Lee SS, Kim TK, Byun JH, Ha HK, Kim PN, Kim AY, et al: Hepatic arteries in potential donors for living related liver transplantation: evaluation with multi-detector row CT angiography. Radiology 2003; 227: 391-399. (Pubitemid 36514752)
41. Kalra MK, Maher MM, Blake MA, Lucey BC, Karau K, Toth TL, et al: Detection and characterization of lesions on low-radiation-dose abdominal CT images postprocessed with noise reduction filters. Radiology 2004; 232: 791-797. (Pubitemid 39100265)
42. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N: Cirrhosis or chronic hepatitis: evaluation of small (< or =2 cm) early-enhancing hepatic lesions with serial contrast- enhanced dynamic MR imaging. Radiology 2003; 226: 550-555. (Pubitemid 36313448)
43. Ito K, Fujita T, Shimizu A, Koike S, Sasaki K, Matsunaga N, et al: Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol 2004; 183: 699-705. (Pubitemid 39145317)
44. Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, et al: Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography. Hepatol Res 2003; 27: 196-204. (Pubitemid 37407667)
45. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al: Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205-212. (Pubitemid 30614651)
46. Ba-Ssalamah A, Schima W, Schmook MT, Linnau KF, Schibany N, Helbich T, et al: Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liverspecific MR contrast agents. AJR Am J Roentgenol 2002; 179: 1447-1456. (Pubitemid 35386642)
47. Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, et al: Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 2002; 179: 1045-1051.
48. Arbab AS, Ichikawa T, Sou H, Araki T, Nakajima H, Ishigame K, et al: Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. Radiology 2002; 225: 151-158.
49. Bluemke DA, Weber TM, Rubin D, de Lange EE, Semelka R, Redvanly RD, et al: Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol. Radiology 2003; 228: 457-464. (Pubitemid 36910088)
50. Bhartia B, Ward J, Guthrie JA, Robinson PJ: Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003; 180: 577-584. (Pubitemid 36237194)
51. Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT: Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 2003; 228: 719-726. (Pubitemid 37025482)
52. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al: Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230: 266-275. (Pubitemid 37549812)
53. Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al: Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200: 59-67. (Pubitemid 26197732)
54. Jung G, Breuer J, Poll LW, Koch JA, Balzer T, Chang S, et al: Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47: 15-23. (Pubitemid 43177525)
55. Narita M, Hatano E, Arizono S, Miyagawa- Hayashino A, Isoda H, Kitamura K, et al: Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009; 44: 793-798.
56. Tsuda N, Matsui O: Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi - gadoxetic acid-enhanced MR imaging. Radiology 2010; 256: 767-773.
57. Saito K, Kotake F, Ito N, Ozuki T, Mikami R, Abe K, et al: Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 2005; 4: 1-9.
58. Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, et al: Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 2010; 32: 903-913.
59. Kudo M: The 2008 Okuda lecture: management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol 2010; 439-452.
60. Kudo M: Will Gd-EOB MRI change the diagnostic algorithm for hepatocellular carcinoma? Oncology 2010;S87-93.
61. Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, et al: Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010; 20: 2405-2413.
62. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al: Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010; 45: 133-141.
63. Kojiro M, Wanless I, Alves V, et al: Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-664.
64. Imai Y, Murakami T, Hori M, Fukuda K, Kim T, Marukawa T, et al: Hypervascular hepatocellular carcinoma: combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP. Hepatol Res 2008; 38: 147-158.
65. Kudo M: Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009; 44(suppl 19):112-118.
66. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M: Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002; 225: 143-149.
67. Kudo M, Okanoue T, Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72(suppl 1):2-15. (Pubitemid 350256660)